Tumor-infiltrating M-MDSCs produce CCR5 ligands CCL3, CCL4, and CCL5, and meanwhile, Tregs exhibit high surface expression of CCR5 and are recruited to tumor tissue by CCL4 and CCL5. The gene discussed is CCL5; the disease is neoplasm.